Welqut Protease

Welqut Protease Staphylococcus aureus Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to Welqut Protease

Welqut Protease is a highly specific recombinant serine protease derived from Staphylococcus aureus. It is engineered to cleave proteins at the engineered recognition sequence W-E-L-Q↓X (Trp, Glu, Leu, Gln, where X represents any amino acid), enabling precise removal of N-terminal fusion tags without leaving residual amino acids on the target protein . This enzyme has become a critical tool in recombinant protein purification workflows due to its specificity, broad activity range, and procedural advantages .

Key Properties

ParameterDetails
SourceRecombinant Staphylococcus aureus (expressed in Escherichia coli)
Molecular Mass22 kDa (204 amino acids)
Optimal pH6.5–9.0
Temperature Range4°C–30°C
Purity>97% (SDS-PAGE)
Storage-20°C (long-term); 4°C for 2–4 weeks

Formulation

  • Buffer Composition: 10 mM Na₂HPO₄, 1.8 mM KH₂PO₄, 140 mM NaCl, 2.7 mM KCl, 50% glycerol (pH 7.3) .

  • His-Tag: Built-in hexahistidine tag for easy removal via immobilized metal affinity chromatography (IMAC) .

Mechanism of Action

Welqut Protease cleaves C-terminal to the WELQ motif, releasing the target protein without adding extraneous residues . Key mechanistic features include:

  • Substrate Specificity: Requires the WELQX sequence but tolerates variability at the X position .

  • Catalytic Efficiency: Retains activity under diverse conditions, including high ionic strength and non-reducing environments .

Protein Purification

  • On-Column Cleavage: Ideal for affinity tag removal during immobilized metal affinity chromatography (IMAC) .

  • Fusion Protein Processing: Used to liberate bioactive peptides (e.g., bacteriocins) from GFP fusion partners .

Biosensor Development

  • FRET-Based Sensors: Integrated into constructs with mWatermelon and mScarlet-I fluorescent proteins to monitor protease activity dynamically .

Cleavage Efficiency

  • Optimal Ratios:

    Fusion ProteinWELQut:Sample RatioIncubation TimeEfficiency
    GFP-PlaX1:10 (µL:µL)16 hComplete
    GFP-MunX1:25 (µL:µL)16 hPartial
    Data from bacteriocin-GFP fusion cleavage experiments .
  • Challenges:

    • Incomplete cleavage observed with GFP-MunX due to potential interactions between liberated bacteriocins and the protease’s N-terminus .

    • Fluorescent SDS-PAGE confirmed cleavage via band shifts (~20 kDa increase post-cleavage) .

Activity Validation

  • Antimicrobial activity of cleaved bacteriocins (e.g., plantaricin 423, mundticin ST4SA) was confirmed using semi-native SDS-PAGE overlays .

Comparative Advantages Over TEV Protease

FeatureWelqut ProteaseTEV Protease
Redox SensitivityInsensitive (serine protease)Requires reducing conditions
Buffer FlexibilityCompatible with non-reducing buffersLimited to reducing buffers
Tag RemovalNo residual amino acidsMay leave short sequences

Protocol Recommendations

  • Small-Scale Optimization: Test enzyme:protein ratios (1:100 to 1:5 U/µg) and temperatures (4°C–30°C) using 50 µg target protein .

  • On-Column Workflow:

    1. Equilibrate IMAC resin.

    2. Load fusion protein and WELQut protease (1:10–1:20 U/µg).

    3. Incubate at 15°C–30°C for 16 h .

Product Specs

Introduction

The WELQut Protease, derived from Staphylococcus aureus, is a highly specific recombinant serine protease. It demonstrates exceptional precision in identifying and cleaving recombinant proteins possessing a specific recognition sequence: Trp, Glu, Leu, Gln, followed by any amino acid (X). Notably, the cleavage occurs externally to this recognition sequence, ensuring no extra amino acids remain attached to the target protein. This protease exhibits remarkable versatility, functioning effectively across a temperature range of 4-30°C and a pH range of 6.5-9.0, without the need for specific buffers.

Description

The recombinant Welqut Protease is a single, non-glycosylated polypeptide chain with a molecular weight of 22kDa, composed of 204 amino acids. Its purification is achieved through proprietary chromatographic techniques.

Physical Appearance
A colorless solution that has undergone sterile filtration.
Formulation

The formulation of Welqut Protease consists of 10 mM Na2HPO4, 50% glycerol, 1.8 mM KH2PO4, with a pH of 7.3, 140 mM NaCl, and 2.7 mM KCl.

Stability
For optimal storage, refrigerate at 4°C if the entire vial will be used within 2-4 weeks. For longer-term storage, freezing at -20°C is recommended. To further enhance stability during long-term storage, consider adding a carrier protein such as 0.1% HSA or BSA. It is important to minimize repeated freeze-thaw cycles.
Purity

SDS-PAGE analysis indicates a purity exceeding 97.0%.

Unit Definition

One unit of enzyme activity is defined as the amount required to cleave 99% or more of 100 micrograms of a control protein within 16 hours at a temperature of 20°C. The enzyme activity assay is conducted in a volume of 100 microliters of 100 mM Tris-HCl buffer at pH 8.0.

Source

Escherichia Coli.

Q&A

What is WELQut Protease and what is its recognition sequence?

WELQut Protease is an extremely specific recombinant serine protease derived from Staphylococcus aureus. It recognizes and precisely cleaves recombinant proteins containing the engineered recognition sequence W-E-L-Q↓X (Tryptophan-Glutamic acid-Leucine-Glutamine-X, where X can be any amino acid) . The protease cleaves immediately after the glutamine residue and externally from the recognition sequence, which is a significant advantage as it does not leave additional amino acids bound to the target protein . This 22 kDa monomeric enzyme consists of 204 amino acids in a single, non-glycosylated polypeptide chain .

Under what conditions does WELQut Protease function optimally?

WELQut Protease demonstrates remarkable versatility in its operating conditions, functioning effectively across a broad temperature range (4-30°C) and pH range (6.5-9.0) . This flexibility eliminates the need for specific buffers, making it adaptable to various experimental setups. The standard assay conditions define one unit of activity as the amount of enzyme required to cleave ≥99% of 100μg of a control protein in 16 hours at 20°C, typically in 100μl of 100 mM Tris-HCl (pH 8.0) . For optimal storage stability, the enzyme is formulated with 10 mM Na₂HPO₄, 50% glycerol, 1.8 mM KH₂PO₄, pH 7.3, 140 mM NaCl, and 2.7 mM KCl . Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage, and multiple freeze-thaw cycles should be avoided .

What are the primary applications of WELQut Protease in recombinant protein research?

WELQut Protease serves several critical functions in recombinant protein research:

  • Tag removal: Its primary application is the removal of N-terminal fusion tags from recombinant protein preparations .

  • On-column proteolysis: The enzyme is particularly suitable for on-column proteolysis reactions, allowing for streamlined protein purification workflows .

  • Purification after cleavage: WELQut Protease contains a built-in His-tag that facilitates its easy removal from reaction mixtures after cleavage, simplifying downstream processing .

  • Bacteriocin research: It has been employed in studies involving bacteriocin fusion proteins such as GFP-PlaX and GFP-MunX to liberate active bacteriocins .

How should WELQut cleavage reactions be optimized for fusion proteins?

Optimization of WELQut cleavage reactions requires systematic evaluation of multiple parameters. Based on research with GFP-fusion proteins, the following methodology is recommended:

  • Determine optimal protease-to-sample ratios: Test various ratios (e.g., 1:10, 1:25, 1:50 μL:μL) of WELQut to fusion protein .

  • Establish time-course analysis: Monitor cleavage efficiency at different time points (e.g., 2, 4, 8, and 16 hours) to determine the optimal incubation duration .

  • Control incubation temperature: Maintain reactions at a consistent temperature (typically 20-28°C) throughout the optimization process .

  • Verify cleavage efficiency: For fluorescent fusion partners like GFP, visualize migration patterns of fluorescent bands after electrophoretic separation to assess cleavage progress .

  • Confirm biological activity: Validate that the cleaved target protein retains its expected biological activity post-cleavage .

The table below summarizes experimental optimization conditions based on bacteriocin fusion protein research:

ParameterGFP-PlaX Optimal ConditionsGFP-MunX Optimal Conditions
WELQut:sample ratio1:10 (μL:μL)1:25 (μL:μL)
Incubation temperature28°C28°C
Optimal incubation time16 hours16 hours
Complete cleavage achieved?YesNo (slight uncleaved band remained)
Antimicrobial activity post-cleavageConfirmedConfirmed
Activity units post-cleavage83.33 BU/mL1600 BU/mL

What strategies can improve cleavage efficiency when working with difficult fusion proteins?

For challenging fusion proteins that demonstrate suboptimal cleavage with WELQut Protease, several strategies can be implemented:

  • Adjust buffer conditions: While WELQut functions across a wide pH range, subtle adjustment of buffer components may improve accessibility of the cleavage site.

  • Modify reaction temperature: Testing temperatures within the 4-30°C range may identify optimal conditions for specific fusion constructs .

  • Increase incubation time: For difficult-to-cleave proteins, extending incubation beyond the standard 16 hours may improve yields, though this should be balanced against the risk of protein degradation .

  • Ensure proper protein folding: Misfolded proteins may obscure the WELQ recognition site; consider adding low concentrations of mild denaturants to partially unfold the protein.

  • Incorporate flexible linkers: When designing fusion constructs, include flexible linker sequences between the tag and target protein to improve accessibility of the cleavage site.

  • Evaluate potential complex formation: Research has shown that WELQut may form complexes with certain fusion proteins, as evidenced by the observation of larger-than-expected bands (~20 kDa increase) on SDS-PAGE following cleavage attempts . This phenomenon may be protein-specific and should be investigated when troubleshooting cleavage efficiency.

What factors might contribute to inefficient cleavage by WELQut Protease?

Several factors can negatively impact WELQut Protease cleavage efficiency:

  • Complex formation: Studies have reported the formation of a WELQut-fusion protein complex, evidenced by an approximate 20 kDa size increase in SDS-PAGE analysis after cleavage reaction . This complex formation may be related to the protease's mechanism derived from the SpIB protease of S. aureus.

  • Recognition site accessibility: Tertiary structure of the fusion protein may sterically hinder access to the WELQ recognition sequence, particularly if it's located near structured domains .

  • N-terminal interactions: Research suggests that interactions at the N-terminus can affect the dynamics of the SpIB protease (from which WELQut is derived), impacting substrate recognition and hydrolysis .

  • Suboptimal protease:substrate ratio: Using inadequate amounts of protease or excessive substrate can result in incomplete cleavage .

  • Interfering compounds: Components in the reaction buffer or from the protein purification process may inhibit protease activity.

How can researchers detect and characterize WELQut-fusion protein complex formation?

Based on observed limitations with WELQut Protease, researchers should implement the following analytical approaches to detect and characterize potential complex formation:

  • Comparative SDS-PAGE analysis: Perform SDS-PAGE under both reducing and non-reducing conditions, comparing migration patterns before and after cleavage reactions. A size increase of approximately 20 kDa after cleavage may indicate complex formation .

  • Fluorescent fusion partner tracking: Using GFP or other fluorescent tags allows visualization of migration patterns without staining. Observe changes in the molecular weight of fluorescent bands as an indicator of complex formation .

  • Size exclusion chromatography: This technique can separate the cleaved target protein from any protease-fusion complexes based on molecular size.

  • Mass spectrometry: Employ this technique to precisely determine the composition of protein complexes and identify any unexpected associations between WELQut and fusion partners.

  • Anti-His tag detection: Since commercial WELQut contains a His-tag, use anti-His tag antibodies to detect where the protease is located in relation to the cleaved products.

What is the underlying mechanism of WELQut activation and how might target proteins interfere with this process?

WELQut Protease, derived from the SpIB protease of Staphylococcus aureus, undergoes activation through a specific mechanism:

  • Signal peptide cleavage: In its native form, SpIB protease is activated by proteolytic cleavage of an N-terminus signal peptide, which enables the formation of a characteristic hydrogen bond network .

  • Catalytic machinery independence: Research indicates that signal peptide cleavage does not alter the disposition of the catalytic machinery nor disrupt the hydrogen bond network near the catalytic site .

  • N-terminal influence: Interactions at the N-terminus appear to affect the dynamics of the entire protease, which subsequently impacts substrate recognition and hydrolysis efficiency .

Potential interference mechanisms:

How does WELQut Protease compare with other site-specific proteases for fusion tag removal in complex experimental systems?

When comparing WELQut Protease with other commonly used site-specific proteases for fusion tag removal, several factors deserve consideration:

ProteaseRecognition SequenceCleavage SiteLeftover ResiduesTemperature RangepH RangeAdvantages/Limitations
WELQutWELQ↓XAfter QNone4-30°C6.5-9.0Cleaves externally; easy removal via His-tag; potential complex formation
TEVENLYFQ↓G/SAfter QNone (if G/S follows)4-30°C6.0-8.5Highly specific; slower kinetics; activity affected by adjacent residues
ThrombinLVPR↓GSAfter RGS remains on target4-25°C6.5-8.5Widely used; may cause non-specific cleavage; animal-derived
Factor XaIEGR↓XAfter RNone20-25°C6.5-8.5Cleaner cuts than thrombin; slower; animal-derived
PreScissionLEVLFQ↓GPAfter QGP remains on target4-25°C6.0-8.0GST-tagged; can be removed by GST affinity; relatively expensive

For advanced experimental systems:

  • Membrane proteins: WELQut's broad buffer compatibility makes it suitable for membrane protein work where detergents may be present.

  • Multi-domain proteins: The potential for WELQut-protein complex formation should be considered when working with complex multi-domain proteins.

  • In vivo applications: WELQut has not been extensively characterized for in-cell applications, unlike some other proteases.

  • High-throughput applications: The observed inefficiencies in some WELQut cleavage scenarios may limit its utility in high-throughput platforms where consistent, rapid cleavage is essential.

What methodological approaches might resolve the apparent WELQut-GFP-bacteriocin complex formation observed in fusion protein studies?

To address the WELQut-GFP-bacteriocin complex formation observed in previous research , several methodological approaches could be implemented:

  • Modified recognition sequence contexts: Engineer variations in the residues surrounding the WELQ motif to potentially reduce post-cleavage associations.

  • Two-step purification strategy:

    • Perform initial cleavage under standard conditions

    • Apply immobilized metal affinity chromatography (IMAC) to remove His-tagged WELQut and any WELQut-protein complexes

    • Follow with size exclusion chromatography to separate remaining complexes based on molecular weight

  • Competitive peptide approach: Introduce synthetic peptides containing the WELQ sequence that may compete for binding with cleaved fusion proteins, potentially disrupting complex formation.

  • Denaturing conditions post-cleavage: After completing the cleavage reaction, apply mild denaturing conditions that may disrupt protease-product interactions without affecting the target protein's structure.

  • Alternative buffer compositions: Systematically test various buffer compositions, focusing on ionic strength, chelating agents, and mild detergents that might prevent or disrupt complex formation.

  • Molecular dynamics simulations: Conduct computational analysis to predict potential interaction sites between WELQut and target proteins, guiding rational design of modifications to reduce complex formation.

  • Cross-linking and mass spectrometry (XL-MS): Employ this technique to identify specific contact points between WELQut and fusion proteins, providing insights for targeted protein engineering approaches.

How might researchers engineer improved WELQ recognition sequences for enhanced cleavage efficiency in challenging fusion proteins?

Based on the understanding of WELQut Protease's mechanism and observed limitations, researchers can employ several strategies to engineer enhanced WELQ recognition contexts:

  • Flexible linker incorporation: Design constructs with flexible glycine-serine linkers (e.g., GGSGGS) flanking the WELQ motif to improve accessibility to the protease .

  • Context optimization: Analyze the residues immediately surrounding the WELQ↓X sequence, testing variations that might enhance recognition:

    • Explore different amino acids at the X position

    • Optimize residues preceding the W in the recognition sequence

    • Consider secondary structure predictions to ensure the recognition site remains unstructured

  • Dual protease approach: Engineer fusion constructs with multiple orthogonal protease recognition sites (e.g., WELQ plus TEV), providing alternative cleavage options if one proves inefficient.

  • Rational design based on SpIB structure: Utilize structural information about the SpIB protease (WELQut's parent enzyme) to design recognition sequences that optimize interactions with key residues in the protease's binding pocket .

  • Directed evolution approach: Develop a library of variant WELQ recognition contexts and screen for enhanced cleavage efficiency through high-throughput methods.

  • Position effect consideration: Test the impact of the recognition sequence's position within the fusion construct, as proximity to structured domains may affect accessibility.

  • N-terminal interference mitigation: Based on observations that N-terminal interactions affect SpIB dynamics , design constructs that minimize potential interference with the N-terminus of WELQut after cleavage.

What emerging applications might benefit from WELQut Protease's unique cleavage properties?

Several emerging research areas could benefit from the precise cleavage properties of WELQut Protease:

  • Protein therapeutic production: The clean cleavage without leaving residual amino acids makes WELQut potentially valuable for therapeutic protein manufacturing where amino acid additions could affect immunogenicity or activity .

  • Protein semisynthesis: WELQut could facilitate protein semisynthesis approaches by enabling precise fragment generation for subsequent ligation reactions.

  • Biosensor development: Engineered WELQ sites could enable controlled activation of fluorescent or enzymatic reporters in response to specific cellular conditions.

  • Controlled release systems: Incorporation of WELQ recognition sequences in protein-based drug delivery systems could allow for targeted release of therapeutics.

  • Structural biology applications: The ability to precisely remove purification tags without leaving residual amino acids is particularly valuable for structural studies where additional residues might interfere with crystallization or affect protein dynamics.

  • Biomaterial engineering: WELQ recognition sites could serve as specific degradation points in protein-based biomaterials, allowing for controlled degradation under specific conditions.

  • Multi-protein complex assembly: WELQut cleavage could enable controlled release of components in hierarchical assembly processes for complex protein structures.

Based on current research limitations, what modifications to WELQut Protease might enhance its utility in challenging experimental scenarios?

Several potential modifications to WELQut Protease could address the limitations observed in current research:

  • Engineered variants with reduced complex formation: Structure-guided mutagenesis targeting residues involved in post-cleavage associations with target proteins could reduce the complex formation observed in some applications .

  • Higher activity mutants: Directed evolution approaches could yield WELQut variants with enhanced catalytic efficiency, addressing the slow cleavage rates observed in some studies .

  • Fusion-specific optimizations: Development of WELQut variants optimized for specific challenging fusion partners, such as bacteriocins or membrane proteins.

  • Temperature-adaptive variants: Engineering variants with improved activity at lower temperatures (4°C) could enable more efficient cleavage during cold purification workflows.

  • Immobilization-optimized variants: Design of WELQut variants specifically engineered for optimal performance when immobilized on solid supports for on-column cleavage applications.

  • Split-WELQut systems: Development of split-protease systems that reassemble only under specific conditions, enabling spatiotemporal control of cleavage activity.

  • Allosterically regulated variants: Engineering WELQut variants with regulatory domains that modulate activity in response to specific molecules or conditions.

What experimental approaches could further elucidate the molecular basis of WELQut-fusion protein interactions to improve cleavage strategies?

To better understand and address the molecular interactions between WELQut Protease and fusion proteins, researchers should consider these experimental approaches:

  • Structural biology studies: Obtain high-resolution crystal or cryo-EM structures of WELQut in complex with substrate peptides and/or post-cleavage products to identify interaction interfaces.

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Apply this technique to map regions of WELQut and fusion proteins that exhibit altered solvent accessibility upon binding, indicating interaction surfaces.

  • Alanine scanning mutagenesis: Systematically replace residues in both WELQut and around the WELQ recognition site with alanine to identify critical interaction points.

  • Molecular dynamics simulations: Conduct computational analyses of WELQut-substrate interactions to predict binding modes and dynamic changes during the catalytic cycle.

  • Surface plasmon resonance (SPR) analysis: Quantitatively measure binding kinetics between WELQut and various substrate peptides or cleaved products to characterize affinity and residence times.

  • Fluorescence resonance energy transfer (FRET): Design FRET-based assays to monitor real-time interactions between labeled WELQut and fusion proteins.

  • In vitro evolution and deep mutational scanning: Generate libraries of WELQut variants and systematically assess their cleavage efficiency against various substrates to identify sequence-function relationships.

  • Comparative analysis with other S. aureus serine proteases: Examine related proteases to identify unique features of WELQut that might contribute to observed complex formation .

  • Isothermal titration calorimetry (ITC): Characterize the thermodynamics of WELQut-substrate interactions to better understand the energetic basis of complex formation.

Product Science Overview

Structure and Composition

Welqut Protease is a single, non-glycosylated polypeptide chain consisting of 210 amino acids, with a molecular mass of approximately 22 kDa . The enzyme is fused to a six-amino-acid His-tag at its C-terminus, which facilitates its purification and removal from reaction mixtures .

Recognition Sequence and Cleavage Specificity

The protease recognizes an engineered recognition sequence, W-E-L-Q↓X, where X can be any amino acid . This sequence is typically added to recombinant proteins to allow for precise cleavage. The enzyme cleaves outside the recognition sequence without leaving additional amino acids bound to the target protein, ensuring that the integrity of the target protein is maintained .

Activity and Stability

Welqut Protease is active over a broad temperature range (4°C to 30°C) and pH range (6.5 to 9.0), making it versatile for various experimental conditions . It does not require specific buffers, which simplifies its use in different applications . The enzyme is stable when stored at 4°C for short-term use and at -20°C for long-term storage, with the addition of a carrier protein recommended to enhance stability .

Applications

Welqut Protease is primarily used for the removal of N-terminal fusion tags from recombinant protein preparations . Its high specificity and ability to cleave without leaving additional residues make it ideal for on-column proteolysis reactions . The built-in His-tag allows for easy removal of the protease from reaction mixtures, further enhancing its utility in protein purification processes .

Advantages
  • High Specificity: The enzyme is highly specific to its recognition sequence and does not generate non-specific product bands, even after prolonged incubation or when used in excess .
  • Ease of Use: The protease can be easily removed from reaction mixtures using its built-in His-tag, simplifying downstream processing .
  • Versatility: Active across a wide range of temperatures and pH levels, Welqut Protease does not require specific buffers, making it adaptable to various experimental conditions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.